|
|
Volumn 312, Issue 7031, 1996, Pages 640-
|
|
Incidence of and mortality from breast cancer since introduction of screening. Several factors must have a role in improved figures.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
TAMOXIFEN;
AGED;
BREAST TUMOR;
FEMALE;
HUMAN;
MASS SCREENING;
MIDDLE AGED;
MORTALITY;
NOTE;
SURVIVAL RATE;
TIME;
TREATMENT OUTCOME;
UNITED KINGDOM;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
MASS SCREENING;
MIDDLE AGED;
SCOTLAND;
SURVIVAL RATE;
TAMOXIFEN;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0030576093
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.312.7031.640 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
